Advertisement SpectraScience obtains new European patent for Optical Biopsy System - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

SpectraScience obtains new European patent for Optical Biopsy System

SpectraScience, a San Diego based medical device company, has received a European patent for its Optical Biopsy System for tissue diagnosis.

Jim Hitchin, SpectraScience’s CEO, said: “This patent is important to the company’s optical biopsy technology because it provides protection in the areas of tissue surveillance, characterization, diagnosis and treatment. It supports the company’s fundamental technology of non-invasive, low-level laser diagnosis of pre-cancerous and cancerous tissue.

“This is another key patent in our intellectual property portfolio that underscores our commitment at SpectraScience to develop better, more reliable cancer screening technologies.”